Pulmatrix, Inc. ( PULM) - Key Metrics
PULM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.28 | -$0.30 | -$0.30 |
| 2026Q1 | $0 | -$0.32 | -$0.29 | -$0.29 |
| 2025Q4 | $0 | -$0.25 | -$0.19 | -$0.19 |
| 2025Q3 | $0 | -$0.24 | -$0.28 | -$0.28 |
| 2025Q2 | $0 | -$0.42 | -$0.52 | -$0.52 |
PULM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.47 |
| 2026Q1 | 0% | -1.01 |
| 2025Q4 | 0% | -2.23 |
| 2025Q3 | 0% | -5.06 |
| 2025Q2 | 0% | -4.11 |
PULM
Price: $1.50
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23200
Ebitda: -4.2 millionMarket Capitalization: 5.7 million